Article
The impact of SETBP1 mutations in neurological diseases and cancer.
Genes to cells : devoted to molecular & cellular mechanisms - 1 Sept 2023
Kohyanagi Naoki, Ohama Takashi
Abstract excerpt
SE translocation (SET) is a cancer-promoting factor whose expression is upregulated in many cancers. High SET expression positively correlates with a poor cancer prognosis. SETBP1 (SET-binding protein 1/SEB/MRD29), identified as SET-binding protein, is the causative gene of Schinzel-Giedion syndrome, which is characterized by severe intellectual disability and a distorted facial appearance. Mutations in these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
